Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.
León L, Cueva-Banuelos JF, Huidobro G, Fírvida JL, Amenedo M, Lázaro M, Romero C, Estévez SV, Barón FJ, Grande C, García Mata J, González A, Castellanos J, Gómez A, Caeiro M, Rodríguez MR, Casal J; Galician Lung Cancer Group. León L, et al. Among authors: baron fj. Lung Cancer. 2003 May;40(2):215-20. doi: 10.1016/s0169-5002(03)00030-8. Lung Cancer. 2003. PMID: 12711124
Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
Mariscal J, Alonso-Nocelo M, Muinelo-Romay L, Barbazan J, Vieito M, Abalo A, Gomez-Tato A, Maria de Los Angeles CC, Garcia-Caballero T, Rodriguez C, Brozos E, Baron F, Lopez-Lopez R, Abal M. Mariscal J, et al. Among authors: baron f. Sci Rep. 2016 Nov 30;6:37820. doi: 10.1038/srep37820. Sci Rep. 2016. PMID: 27901069 Free PMC article.
Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.
Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, Aguín S, Abal M, López RL. Muinelo-Romay L, et al. Among authors: baron f. Cancers (Basel). 2014 Jan 21;6(1):153-65. doi: 10.3390/cancers6010153. Cancers (Basel). 2014. PMID: 24452143 Free PMC article.
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.
Viñolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sánchez-Torres JM, Barón FJ, Cobo M, Maestu I, Moreno I, Mesía C, Izquierdo A, Felip E, López-Brea M, Márquez A, Sánchez-Ronco M, Tarón M, Santarpia MC, Rosell R; Spanish Lung Cancer Group. Viñolas N, et al. Among authors: baron fj. Lung Cancer. 2011 Feb;71(2):191-8. doi: 10.1016/j.lungcan.2010.05.005. Lung Cancer. 2011. PMID: 20627363
Dacarbazine in advanced squamous cell carcinoma of the head and neck.
Buesa JM, Fernández R, Barón FJ, Palacio I, Cueva J, Esteban E, Gracia JM. Buesa JM, et al. Among authors: baron fj. Eur J Cancer. 1991;27(2):215-6. doi: 10.1016/0277-5379(91)90492-v. Eur J Cancer. 1991. PMID: 1827292 No abstract available.
547 results